Unitaid transparency policy
Policy on ethics and conflict of interest for Unitaid
Unitaid’s climate and health strategy 2023-2027
Unitaid’s investment case 2023-2027, executive summary
Unitaid’s investment case 2023-2027
Unitaid Strategy 2023-2027
Maternal and newborn health
Women’s and children’s health
Building climate-resilient, sustainable, and low-carbon health supply chains: key priorities for collective action
Gonorrhea point-of-care diagnostics technology and market landscape
Screening and treatment of precancerous lesions for secondary prevention of cervical cancer
Landscape report on commodity and service delivery innovations for detection and management of pre-eclampsia
Medical oxygen innovation landscape
The untold story of dolutegravir: When climate impact goes hand-in-hand with access to better treatments
Antimalarial manufacturing in Africa: A call for regional action
Enabling a market-based approach to manufacturing quality-assured health products in Africa: A differentiated coordination approach
Unitaid audited financial report for the year ended 31 December 2021
Unitaid audited financial report for the year ended 31 December 2020
Unitaid audited financial report for the year ended 31 December 2019
Unitaid audited financial report for the year ended 31 December 2018
Thematic Narrative for Reproductive, Maternal, Newborn and Child Health (RMNCH)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: policy brief (April 2016)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: 2015 – 2018 (April 2016)
Global malaria diagnostic and artemisinin treatment commodities demand forecast: forecasting methodology (April 2016)
Malaria diagnostics technology and market landscape: 3rd edition
Faster, cheaper, better ways to end HIV
Unitaid audited financial report for the year ended 31 December 2015
